These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23399382)

  • 1. Nicotine enhances antisaccade performance in schizophrenia patients and healthy controls.
    Petrovsky N; Ettinger U; Quednow BB; Landsberg MW; Drees J; Lennertz L; Frommann I; Heilmann K; Sträter B; Kessler H; Dahmen N; Mössner R; Maier W; Wagner M
    Int J Neuropsychopharmacol; 2013 Aug; 16(7):1473-81. PubMed ID: 23399382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-cholinergic modulation of antisaccade performance: a modafinil-nicotine comparison.
    Rycroft N; Hutton SB; Clowry O; Groomsbridge C; Sierakowski A; Rusted JM
    Psychopharmacology (Berl); 2007 Dec; 195(2):245-53. PubMed ID: 17676402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Separate and combined effects of low dose ketamine and nicotine on behavioural and neural correlates of sustained attention.
    Knott VJ; Millar AM; McIntosh JF; Shah DK; Fisher DJ; Blais CM; Ilivitsky V; Horn E
    Biol Psychol; 2011 Sep; 88(1):83-93. PubMed ID: 21742012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antisaccade task as an index of sustained goal activation in working memory: modulation by nicotine.
    Rycroft N; Hutton SB; Rusted JM
    Psychopharmacology (Berl); 2006 Nov; 188(4):521-9. PubMed ID: 16896958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine differentially modulates antisaccade performance in healthy male non-smoking volunteers stratified for low and high accuracy.
    Petrovsky N; Ettinger U; Quednow BB; Walter H; Schnell K; Kessler H; Mössner R; Maier W; Wagner M
    Psychopharmacology (Berl); 2012 May; 221(1):27-38. PubMed ID: 22038536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of procyclidine on eye movements in schizophrenia.
    Ettinger U; Kumari V; Zachariah E; Galea A; Crawford TJ; Corr PJ; Taylor D; Das M; Sharma T
    Neuropsychopharmacology; 2003 Dec; 28(12):2199-208. PubMed ID: 12942142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls.
    Barr RS; Culhane MA; Jubelt LE; Mufti RS; Dyer MA; Weiss AP; Deckersbach T; Kelly JF; Freudenreich O; Goff DC; Evins AE
    Neuropsychopharmacology; 2008 Feb; 33(3):480-90. PubMed ID: 17443126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of nicotine on saccadic eye movement latencies in non-smokers.
    Bowling AC; Donnelly JF
    Hum Psychopharmacol; 2010 Jul; 25(5):410-8. PubMed ID: 20589920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nicotine on response inhibition and interference control.
    Ettinger U; Faiola E; Kasparbauer AM; Petrovsky N; Chan RC; Liepelt R; Kumari V
    Psychopharmacology (Berl); 2017 Apr; 234(7):1093-1111. PubMed ID: 28150023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double dissociation of working memory and attentional processes in smokers and non-smokers with and without nicotine.
    Grundey J; Amu R; Ambrus GG; Batsikadze G; Paulus W; Nitsche MA
    Psychopharmacology (Berl); 2015 Jul; 232(14):2491-501. PubMed ID: 25721074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of transdermal nicotine on attention in adult non-smokers with and without attentional deficits.
    Poltavski DV; Petros T
    Physiol Behav; 2006 Mar; 87(3):614-24. PubMed ID: 16466655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind placebo-controlled experimental study of nicotine: II--Effects on response inhibition and executive functioning.
    Dawkins L; Powell JH; West R; Powell J; Pickering A
    Psychopharmacology (Berl); 2007 Mar; 190(4):457-67. PubMed ID: 17205318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of nicotine replacement therapy on agitation in smokers with schizophrenia: a double-blind, randomized, placebo-controlled study.
    Allen MH; Debanné M; Lazignac C; Adam E; Dickinson LM; Damsa C
    Am J Psychiatry; 2011 Apr; 168(4):395-9. PubMed ID: 21245085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of transdermal nicotine on prose memory and attention in smokers and nonsmokers.
    Poltavski DV; Petros T
    Physiol Behav; 2005 Jan; 83(5):833-43. PubMed ID: 15639169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of prepulse inhibition and Wisconsin Card Sorting Test in schizophrenia and controls: effects of smoking status.
    Rabin RA; Sacco KA; George TP
    Schizophr Res; 2009 Oct; 114(1-3):91-7. PubMed ID: 19656658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers.
    Ferguson SG; Gitchell JG; Shiffman S; Sembower MA
    Clin Ther; 2009 Sep; 31(9):1957-65. PubMed ID: 19843485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotine effects on anterior cingulate cortex in schizophrenia and healthy smokers as revealed by EEG-informed fMRI.
    Mobascher A; Warbrick T; Brinkmeyer J; Musso F; Stoecker T; Jon Shah N; Winterer G
    Psychiatry Res; 2012 Nov; 204(2-3):168-77. PubMed ID: 23137805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nicotine nasal spray on cognitive function in schizophrenia.
    Smith RC; Warner-Cohen J; Matute M; Butler E; Kelly E; Vaidhyanathaswamy S; Khan A
    Neuropsychopharmacology; 2006 Mar; 31(3):637-43. PubMed ID: 16160711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating heavy smokers in primary care with the nicotine nasal spray: randomized placebo-controlled trial.
    Stapleton JA; Sutherland G
    Addiction; 2011 Apr; 106(4):824-32. PubMed ID: 21205043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.